WO1991019195A3 - Methode de detection et/ou de dosage des hormones et anticorps utilisables dans ladite methode de detection - Google Patents

Methode de detection et/ou de dosage des hormones et anticorps utilisables dans ladite methode de detection Download PDF

Info

Publication number
WO1991019195A3
WO1991019195A3 PCT/FR1991/000427 FR9100427W WO9119195A3 WO 1991019195 A3 WO1991019195 A3 WO 1991019195A3 FR 9100427 W FR9100427 W FR 9100427W WO 9119195 A3 WO9119195 A3 WO 9119195A3
Authority
WO
WIPO (PCT)
Prior art keywords
hormones
antibodies
assaying
detecting
assayed
Prior art date
Application number
PCT/FR1991/000427
Other languages
English (en)
Other versions
WO1991019195A2 (fr
Inventor
Marie-Christine Maurel
Original Assignee
Agronomique Inst Nat Rech
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech, Centre Nat Rech Scient filed Critical Agronomique Inst Nat Rech
Priority to US07/952,866 priority Critical patent/US5674700A/en
Priority to DE69124511T priority patent/DE69124511T2/de
Priority to EP91910511A priority patent/EP0533719B1/fr
Publication of WO1991019195A2 publication Critical patent/WO1991019195A2/fr
Publication of WO1991019195A3 publication Critical patent/WO1991019195A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Abstract

Méthode de détection et/ou de dosage des hormones y compris les hormones placentaires et des anticorps utilisables dans ladite méthode de détection. Cette méthode, augmentant la sensibilité et la spécificité de la détection et/ou du dosage immunologique d'hormones humaines ou animales, dans des milieux de culture ou dans des fluides biologiques, mettant en ÷uvre au moins deux anticorps identiques ou différents, spécifiques de l'hormone à doser, est caractérisée en ce qu'au moins l'un desdits anticorps est préincubé dans un milieu contenant du plasma ou du sérum dépourvu de l'hormone à détecter et/ou à doser (milieu INC).
PCT/FR1991/000427 1990-06-01 1991-05-30 Methode de detection et/ou de dosage des hormones et anticorps utilisables dans ladite methode de detection WO1991019195A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US07/952,866 US5674700A (en) 1990-06-01 1991-05-30 Method for the detection and/or assay of hormones, and antibodies which can be used in the said detection method
DE69124511T DE69124511T2 (de) 1990-06-01 1991-05-30 Verfahren für den nachweis und/oder die bestimmung von hormonen
EP91910511A EP0533719B1 (fr) 1990-06-01 1991-05-30 Methode de detection et/ou de dosage des hormones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR90/06863 1990-06-01
FR9006863A FR2662804B1 (fr) 1990-06-01 1990-06-01 Anticorps polyclonaux anti-lh et leurs applications a la detection et/ou au dosage de la lh, chez de multiples especes animales.

Publications (2)

Publication Number Publication Date
WO1991019195A2 WO1991019195A2 (fr) 1991-12-12
WO1991019195A3 true WO1991019195A3 (fr) 1992-01-09

Family

ID=9397207

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1991/000427 WO1991019195A2 (fr) 1990-06-01 1991-05-30 Methode de detection et/ou de dosage des hormones et anticorps utilisables dans ladite methode de detection

Country Status (13)

Country Link
US (1) US5674700A (fr)
EP (1) EP0533719B1 (fr)
AT (1) ATE148562T1 (fr)
AU (1) AU7958091A (fr)
DE (1) DE69124511T2 (fr)
DK (1) DK0533719T3 (fr)
ES (1) ES2099746T3 (fr)
FR (1) FR2662804B1 (fr)
IE (1) IE911894A1 (fr)
NZ (1) NZ238394A (fr)
PT (1) PT97839B (fr)
WO (1) WO1991019195A2 (fr)
ZA (1) ZA914121B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3479100B2 (ja) * 1993-06-02 2003-12-15 帝国臓器製薬株式会社 免疫化学的簡易半定量方法および装置
WO1998048273A1 (fr) * 1997-04-23 1998-10-29 Harrison Richard J Procede de detection de fecondite
US20010023070A1 (en) * 1998-05-29 2001-09-20 Reinhard Ebner Interleukins-21 and 22
EP1143250A3 (fr) * 2000-04-03 2004-11-17 Inverness Medical Switzerland GmbH Méthodes d'essai et dispositifs pour les isoformes d'un analyte
EP1143249B1 (fr) * 2000-04-03 2014-01-15 Alere Switzerland GmbH Méthodes d'essai et dispositifs pour les isoformes d'un analyte
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
CA2406607C (fr) * 2000-04-26 2011-08-02 Land O'lakes, Inc. Procede de traitement de proteines du soja et produit a base de proteines du soja obtenu selon ledit procede
US8592219B2 (en) * 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
WO2006076371A2 (fr) * 2005-01-10 2006-07-20 Baylor College Of Medicine Methode d'immunohistochimie quantitative et d'hybridation in situ
WO2006075965A1 (fr) * 2005-01-17 2006-07-20 Gyros Patent Ab Procede de detection d'une substance a analyser au moins bivalente au moyen de deux reactifs d'affinite
WO2010005738A1 (fr) 2008-06-16 2010-01-14 Duke University Capteurs chimiques et leurs procédés de fabrication et d’utilisation
US9958442B2 (en) * 2009-02-11 2018-05-01 Duke University Sensors incorporating antibodies and methods of making and using the same
CN102297966A (zh) * 2011-05-27 2011-12-28 天津农学院 一种半定量检测孕酮胶体金试纸条及其制备方法
WO2013153291A1 (fr) 2012-04-12 2013-10-17 Repropharm Procede et trousse de detection du pic preovulatoire de lh
WO2015127288A1 (fr) 2014-02-20 2015-08-27 Alder Biopharmaceuticals, Inc. Anticorps anti-acth et leur utilisation
WO2015187227A2 (fr) 2014-03-13 2015-12-10 Duke University Plate-forme électronique pour la détection et la commande de réactions électrochimiques
CN105445256A (zh) * 2014-09-02 2016-03-30 江苏泽成生物技术有限公司 促黄体生成素lh定量测定试剂盒及其制备方法与检测方法
CN105424937B (zh) * 2015-10-05 2017-11-21 华中农业大学 一种猴早期妊娠检测的孕酮胶体金免疫层析试纸条
JP6959883B2 (ja) * 2018-02-28 2021-11-05 株式会社あすか製薬メディカル オキシトシンの定量方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991174A (en) * 1970-07-20 1976-11-09 Rafa Laboratories Ltd. Method of determining concentration of luteinizing hormone in body fluid
EP0098590A2 (fr) * 1982-07-05 1984-01-18 Roche Diagnostics GmbH Procédé d'essai immunologique
EP0193881A2 (fr) * 1985-03-06 1986-09-10 Roche Diagnostics GmbH Méthode et réactif pour la détermination de l'hormone lutéinisante ainsi que l'anticorps monoclonal approprié

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates
SE432485B (sv) * 1974-11-11 1984-04-02 Carter Wallace Sett att bestemma prolaktin och medel herfor
US4559145A (en) * 1982-06-16 1985-12-17 Amf Incorporated Process for preparing a zero standard serum
US4935147A (en) * 1985-12-20 1990-06-19 Syntex (U.S.A.) Inc. Particle separation method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991174A (en) * 1970-07-20 1976-11-09 Rafa Laboratories Ltd. Method of determining concentration of luteinizing hormone in body fluid
EP0098590A2 (fr) * 1982-07-05 1984-01-18 Roche Diagnostics GmbH Procédé d'essai immunologique
EP0193881A2 (fr) * 1985-03-06 1986-09-10 Roche Diagnostics GmbH Méthode et réactif pour la détermination de l'hormone lutéinisante ainsi que l'anticorps monoclonal approprié

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Clinical Immunoassay, volume 12, no. 1, 1989, (US), P.E. Garrett: " Troubleshooting immunoassays", pages 18-20, voir page 20, colonne 1, lignes 4-16 *

Also Published As

Publication number Publication date
AU7958091A (en) 1991-12-31
DE69124511D1 (de) 1997-03-13
EP0533719A1 (fr) 1993-03-31
NZ238394A (en) 1993-04-28
ES2099746T3 (es) 1997-06-01
ZA914121B (en) 1992-03-25
PT97839B (pt) 1998-10-30
DK0533719T3 (da) 1997-08-11
FR2662804A1 (fr) 1991-12-06
IE911894A1 (en) 1991-12-04
DE69124511T2 (de) 1997-07-31
ATE148562T1 (de) 1997-02-15
WO1991019195A2 (fr) 1991-12-12
PT97839A (pt) 1992-02-28
US5674700A (en) 1997-10-07
FR2662804B1 (fr) 1994-05-27
EP0533719B1 (fr) 1997-01-29

Similar Documents

Publication Publication Date Title
WO1991019195A3 (fr) Methode de detection et/ou de dosage des hormones et anticorps utilisables dans ladite methode de detection
CA2130072A1 (fr) Methode de detection d'un agent pathogene au moyen d'un virus
ZA933721B (en) Assay
FR2630827B1 (fr) Dispositif et procede pour la determination qualitative et quantitative rapide de la presence d'un ligand reactif dans un fluide
NL176606C (nl) Werkwijze en cuvet voor het meten van de stollingstijd van een bloedmonster.
ATE15549T1 (de) Methode und reagenzsatz zur feststellung von schwangerschaft.
IE44238L (en) Device for diagnosis of pregnancy
NO932320D0 (no) Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne
EP0113075A3 (fr) Système de réaction d'essai immunologique transportable, procédé pour le diagnostic par essai immunologique et sonde ou support utilisé dans ce procédé
AU1259801A (en) Detection method by pcr
ES8703021A1 (es) Procedimiento para detectar y determinar la concentracion de un analito presente en solucion acuosa
WO1991002590A3 (fr) Analyse immunologique pour detecter et determiner l'antigene de pseudocercosporellose dans les cereales
EP0346119A3 (fr) Essai anti-FC pour détecter des anticorps
IT8921788A0 (it) Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici.
KR860006039A (ko) 췌장의 α-아밀라제를 정량하는 방법 및 시약
CA2213083A1 (fr) Detection de la production d'anticorps
ES8308924A1 (es) "un procedimiento para la preparacion de un complejo inmunologicamente activo".
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
EP0352139A3 (fr) Détection des antigènes ou anticorps
EP0219279A3 (fr) Réactif pour la détection et la mesure des produits de condensation d'acétaldéhyde et d'une protéine dans un fluide ainsi que sa préparation et méthode d'utilisation
ATE242487T1 (de) Verfahren zur bestimmung von schilddrüsen- autoantikörpern
EP0319686A3 (fr) Procédé pour le dosage d'une substance recherchée dans une quantité minuscule de décharge de mamelon et dispositif pour un tel dosage
FR2438844A2 (fr) Procede et appareil d'analyse quantitative par fluorometrie
MARGALIT Pseudomonas diagnostic assay(Patent Application)
Chen et al. SPA coagglutination assay for detection of Yersinia pestis antigen and antibody.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI HU JP KR NO PL RO SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI HU JP KR NO PL RO SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991910511

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991910511

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1991910511

Country of ref document: EP